Michael E. Nursey - 17 Jun 2026 Form 4 Insider Report for Amerant Bancorp Inc. (AMTB)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
18 Jun 2026, 16:55:28 UTC
Prior SEC filing
04 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Julio Pena, as Attorney-in-Fact for Michael E. Nursey

Key filing fact

Michael E. Nursey filed Form 4 for Amerant Bancorp Inc. (AMTB) on 18 Jun 2026.

Key facts

  • This page summarizes Michael E. Nursey's Form 4 filing for Amerant Bancorp Inc. (AMTB).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 18 Jun 2026, 16:55.

Change

  • Previous filing in this sequence was filed on 04 Mar 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002098589 Primary reporting owner

Nursey Michael E.

Relationship
SEVP and Chief Domestic Banking Officer
Address
C/O AMERANT BANCORP INC., 220 ALHAMBRA CR., 12TH FLOOR, CORAL GABLES
Signature
/s/ Julio Pena, as Attorney-in-Fact for Michael E. Nursey
Signature date
18 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AMTB transaction

Class A Common Stock

Options Exercise

Transaction value
Shares
+1,343
Change %
+64%
Price
$0.000000*
Shares after
3,442
Date
17 Jun 2026
Ownership
Direct
Footnotes
F1
AMTB transaction

Class A Common Stock

Tax liability

Transaction value
Shares
-328
Change %
-9.5%
Price
$23.23*
Shares after
3,114
Date
17 Jun 2026
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AMTB transaction Derivative

Restricted Stock Units sign-on

Options Exercise

Transaction value
Shares
-1,343
Change %
-25%
Price
$0.000000*
Shares after
4,030
Date
17 Jun 2026
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
1,343
Exercise price
$0.000000
Footnotes
F1, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each restricted stock unit ("RSU") is the economic equivalent of one share of Class A Common Stock.

Footnote F2

Reflects the shares of Class A Common Stock that were surrendered in order to satisfy the reporting person's tax withholding obligation upon the vesting of RSUs.

Footnote F3

On June 17, 2024, Mr. Nursey was awarded 6,716 RSUs, each representing the right to receive, following vesting, one share of Class A Common Stock. Twenty percent (20%) of the restricted stock units vests on each of the first two anniversaries of the date of grant and the remaining sixty percent (60%) will vest on the third anniversary of the date of grant, provided that Mr. Nursey remains in the continuous service of the Company or a subsidiary through each such date.

SEC remarks

SEVP and Chief Domestic Banking Officer

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .